Viewpoint: Can Integrated Health Care Eliminate Racial Disparities in Cancer Survival?
View web version

Good Morning %%First Name%% %%Last Name%%,

Drug Showcase
SUTENT (sunitinib) for GI, RCC & Neuroendocrine Tumors
This slideshow reviews drug information for SUTENT (sunitinib).
Can Integrated Health Care Eliminate Racial Disparities in Cancer Survival?
Publishers Alliance
Evaluating the safety and efficacy of axitinib in the treatment of advanced renal cell carcinoma
By Orvar Gunnarsson, Nicklas R. Pfanzelter, Roger B. Cohen, Stephen M. Keefe

For more on the latest research and developments in oncology, visit our News section.

Latest News
Weekly Docetaxel Less Effective, More Toxic than CMF in Early Breast Cancer
Long-Term Androgen Deprivation Better Than Short-Term in Prostate Cancer
Orteronel Plus Prednisone Fails to Improve Survival in Metastatic Castration-Resistant Prostate Cancer
American Patients Living Longer After Cancer, But Disparities Remain

Want to receive emails specific to your profession and specialty? Click here to complete your profile.

If you were sent this by a colleague and wish to subscribe to Weekly highlights, please click here.

To unsubscribe from the Weekly Highlights click here.
To manage your entire Cancer Therapy Advisor profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All Cancer Therapy Advisor newsletters are sent from the domain "". When configuring e-mail or spam filter rules, please use this domain name.

© 2015 Haymarket Media Inc
114 West 26th St 4th floor
New York, NY 10001